Home›Companies›Healthcare›Novir

Novir, Inc.

Novir provides preventive health screenings and vaccinations to organizations.

Updated Nov 9, 2026·Latest SEC filing Aug 20, 2026·Suggest an edit

About Novir

Novir is a private company based in Milwaukee, Wisconsin. It has reported $6,953,424 raised in two offerings on Form D since September 2024. Its chief executive is Alexander Kempe.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 6, 2026Aug 20, 2026$3,064,987of $3.9M target5$612KEquityRule 506(b)Form D ↗
Aug 26, 2024Sep 23, 2024amended Apr 17, 2025$3,888,437of $4.8M target19$204KDebtRule 506(b)Form D/A ↗2 earlier filings
Total, two offerings$6,953,424

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Novir's Form D filed Aug 20, 2026.

MB
MB
Mark Bakken
Director
DL
Donald Layden
Director
Also a director at HSP Group and Passage and an executive officer and director at Kasisto.
AA
Akel Akel
Director
Alexander Kempe
Alexander Kempe
President & CEO, director

Sources

  1. SECNOVIR, INC. Form D/A, filed Feb 7, 2025
  2. SECNOVIR, INC. Form D, filed Sep 23, 2024
  3. SECNOVIR, INC. filing history
  4. CompanyNovir leadership team